Since the publication of this article, the authors have identified an error contained in Figure 6 (panel c).
FOXP1
hi /HIP1R lo has been incorrectly listed as FOXP1 hi /HIP1R hi .
The correct figure appears below.
The error has now been rectified, and the correct article appears in this issue. The html and online pdf versions have also been rectified, and now carry the correct paper.
The Publisher would like to apologize for any inconvenience this may have caused. Figure 6 . OS of DLBCL cases (n ¼ 233) according to HIP1R, FOXP1 or combined HIP1R/FOXP1 transcript levels. Data were reanalyzed from the Lenz et al. 6 data set (Gene Expression Omnibus accession no. GSE10846). Kaplan-Meier curves in (a) and (b) were grouped on the basis of the lower quartile Q 1 of HIP1R or higher-than-median FOXP1 transcript values, and both cohorts showed significantly worse outcome, P ¼ 0.0044 and P ¼ 0.0113, respectively. (c) The FOXP1 hi /HIP1R lo subgroup (FOXP1Xmedian/HIP1RpQ 1 ) showed a significantly inferior outcome (P ¼ 0.0004). Leukemia (2014) 
